跳至主要内容
临床试验/EUCTR2013-003564-31-IT
EUCTR2013-003564-31-IT进行中(未招募)1 期

Multicentre, Retrospective Study to Assess Long-Term Outcomes of Chelator-Based Treatment With Trientine in Wilson Disease Patients Withdrawn from Therapy With - N/A

IVAR LTD0 个研究点目标入组 90 人开始时间: 2018年4月26日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Patients aged 1 year to 90 years of age
  • 2. Physician-established diagnosis of Wilson disease based on a Ferenci score = 3
  • 3. Documented treatment with d-Penicillamine, withdrawal of treatment with d-Penicillamine, followed by treatment with trientine for at least 6 months at date of informed consent
  • 4. Able/willing to provide written informed consent.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 1
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 23
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 1

排除标准

  • 1. Incomplete history of medication use for trientine from initial diagnosis to last follow-up
  • 2. Unavailable outcome data for hepatic and neurological course of disease at all assessment time points
  • 3. Patients with acute liver failure and fulminant hepatic disease with fatal outcome.

研究者

发起方
IVAR LTD

相似试验

A study to review Wilson disease patients who have... | 临床试验